Kent J. Thiry, Chairman and CEO, DaVita, Mayor of the DaVita Village
Kent Thiry is chairman and CEO of DaVita, a FORTUNE 200 company with 75,000 teammates and approximately $14 billion in revenues. The company operates in 11 countries globally, delivering clinically differentiated health care to nearly 2 million patients.
DaVita has been the subject of leadership and culture case studies written by both Harvard and Stanford, and taught in many other schools and programs. Kent sits on the Harvard Business School’s advisory board and is regularly invited to speak on leadership and culture at top business schools, companies and not-for-profit leadership groups. In 2016 he founded Let Colorado Vote, a group that has passed four ballot initiatives in the last three years. One re-established the presidential primary in Colorado, a second that opened its primaries to independent voters and the most recent two reformed redistricting practices in the State. In 2018, Kent also founded a Statewide CEO Group, called Colorado Thrives, focused on advancing the quality of life for all Coloradans. He also co-founded both The Aspen Group with Senators Bill Frist and Tom Daschle, and COIN (The Colorado Innovation Network) with Governor Hickenlooper and several others. Kent also is on the Advisory Board of NatureVest, a unit of the Nature Conservancy. Prior to joining DaVita, Kent served in several roles, including chairman and CEO of Vivra Specialty Partners, a specialty health care company; CEO of Vivra, a NYSE health care service company; and partner at Bain & Company. Prior board seats include the Chairman of Oxford Health Plans as well as the Trust for Public Land.
Kent earned his B.A. in political science, with distinction, from Stanford University, where he also was elected to Phi Beta Kappa, in 1978. He earned his M.B.A., with honors, from Harvard Business School in 1983, where he was also elected to the Century Club. In 2013, Kent received the Woodrow Wilson Award for Corporate Citizenship and in 2016 he received the International Bridge Builders Award from the University of Denver. Kent is also an enthusiastic, but only modestly talented, mountain biker!
Cynthia Patton, COO, Amgen
Cynthia M. Patton serves as senior vice president and chief compliance officer, responsible for Amgen’s global privacy and compliance organization. Cynthia joined Amgen in 2005, and most recently was a vice president in the Amgen law department with responsibility for commercial legal activities in the United States. Prior to that position, she served as the lead commercial lawyer for both the oncology and inflammation business units. Before joining Amgen, she spent seven years as general counsel of SCAN Health Plan, a California Health Maintenance Organization (HMO). Prior to SCAN, Cynthia served as assistant general counsel of UniHealth and as a staff attorney in the Division of Enforcement at the SEC. She began her legal career at Atlanta-based Alston & Bird in 1986 before moving to Los Angeles to work in law firms specializing in healthcare corporate and securities law. Cynthia previously served as a board member of Watts Healthcare Corporation and Eisner Pediatric and Family Medical Center. Currently, she is the chair of the Amgen Foundation. She is also a member of the Board of Trustees of Wildwood School, a board member at The Los Angeles Music Center and a board member at Martin Luther King, Jr. Community Hospital in Los Angeles. Cynthia received her juris doctor from The National Law Center at George Washington University and her bachelor’s degree from Vassar College.
Dr. Susan Love, MD, MBA, Chief Visionary Officer, Dr. Susan Love Research Foundation
Susan M. Love, MD, MBA, has dedicated her professional life to the eradication of breast cancer. As chief visionary officer of Dr. Susan Love Research Foundation, she oversees an innovative research program centered on breast cancer cause and prevention. She is also a clinical professor of surgery at UCLA’s David Geffen School of Medicine. One of the founders of the National Breast Cancer Coalition, Dr. Love is well known as a trusted guide to women worldwide through the Foundation’s ImPatient Science® education program and her books, including Dr. Susan Love’s Breast Book, now in its sixth edition. The Foundation’s recent groundbreaking initiatives include the Army of Women®, developed to partner women and scientists to accelerate translational research, and the Health of Women (HOW) Study®, an online cohort study aimed at identifying the cause of breast cancer. Among the Foundation’s collaborative research projects are the development of an NIH-funded self-reading ultrasound technology for triage of palpable breast lumps, an analysis of the anatomy of the breast ductal system, and an investigation into the microbiome of the breast ducts. Dr. Love received her medical degree from SUNY Downstate Medical Center in New York. She trained at Boston’s Beth Israel Hospital, was an early member of the Multidisciplinary Breast Center at Dana Farber Cancer Center, and founded the Faulkner Breast Center and the Revlon UCLA Breast Center. She received her business degree from the Executive MBA program at UCLA’s Anderson School of Management.
Consumerism Panel (5 + Moderator)
Richard Boxer, M.D., FACS, Clinical Professor of Urology, David Geffen School of Medicine at UCLA
As Clinical Professor of Urology at the David Geffen School of Medicine at UCLA, Dr. Boxer is an international leader in telemedicine and a national leader health policy and medical cannabis policy. He graduated from the University of Wisconsin undergraduate and medical schools with high honors and completed his training at UCLA in urology. He has been a health policy adviser to the White House, Senators and Governors. He was appointed to the Boards of the National Cancer Institute and the National Institute of Diabetes, Kidney, and Digestive Diseases. As a private citizen, he represented the US at the World Health Organization. He was finalist for Surgeon General of the US in 1997 and 2001 under the Clinton and Bush Administrations. Dr. Boxer has had OP-EDs recently published in the Wall Street Journal three times (http://www.wsj.com/articles/when-a-doctor-is-always-a-phone-call-away-1438551044 and https://www.wsj.com/articles/itll-take-more-than-a-band-aid-to-fix-medicaid-1486336355, and https://www.wsj.com/articles/can-marijuana-alleviate-the-opioid-crisis-1511104543), the New York Times (http://www.nytimes.com/2016/11/02/opinion/how-health-care-hurts-your-paycheck.html?_r=0), and JAMA (http://jamanetwork.com/journals/jama/fullarticle/2607482), all on health policy.
He is the founding partner of and medical adviser to iAnthus (www.ianthuscapital.com). iAnthus targets vertically integrated cannabis operating companies in high growth markets and ensures operators are focused on building leading regional market share.
The company’s dynamic growth strategy drives each step of operations, from cultivation and processing to retail and marketing. The management team has proven expertise in regulated industries, lobbying, project management, real estate and corporate finance. By implementing expandable, replicable initiatives across multiple operations., Dr. Boxer wrote the seminal OP-ED on the potential use of cannabis to reduce the opioid crisis. The Wall Street Journal published the OP-ED entitled “Can Marijuana Alleviate the Opioid Crisis? The federal government should stop blocking research into the drug’s medical potential.” (https://www.wsj.com/articles/can-marijuana-alleviate-the-opioid-crisis-1511104543)
He has a deep and broad understanding of the telemedicine, health policy, and cannabis. Dr Boxer is a consultant, speaker, thought-leader, and author.
Robert Gellibolian (B.S. '90), Ph.D., Founder & CEO, CellectGen
Robert Gellibolian is the founder and CEO of CellectGen, a digital health technology company, focused on developing saliva-based, consumer-facing next generation point-of-care (POC) tests, devices, and services that empower consumers to easily monitor and track the status of their health, anytime, from anywhere in less than 15 minutes.
The company’s first product is an in-home saliva-based test that measures levels of a biomarker for bone loss to accurately identify early signs of gum disease that affect nearly 50% of American adults.
Robert has a broad background in business as well as product development and commercialization. He has held senior level management and technical positions at House Ear Institute, Agilent Technologies, and DiscoveRx. Robert is an EIR advisor for Children’s Hospital of Los Angeles’ flagship CTIP (Consortium for Technology and Innovation in Pediatrics) program. He holds a Bachelor of Science degree from UCLA and a Ph.D from Texas A&M University, both in biochemistry. He did his post-doctoral research work at the Salk Institute’s Gene Expression Laboratory in San Diego.
Thomas Levin, CEO, Meld Systems, Inc.
Tom Levin is a seasoned senior healthcare executive and entrepreneur with over 30 years experience of P&L accountability. His career has focused on managing large and complex organizations, achieving success in retail and governmental markets, driving innovation in financing and delivering healthcare services, expanding effective use of healthcare information, and understanding governance issues. He is also highly regarded as a healthcare lawyer. His experiences includes 15 years as CEO of managed care companies, CEO of IT development companies, hands-on operating experience, profitability success, and varied roles as an active player developing health policy at the national and state/regional levels. He is known for leadership and team building skills, insight and vision in solving complex business issues, and executing to achieve exceptional results in challenging situations. He is noted for his strategic positioning skills. He has consistently driven market smart programs that integrate market research, advertising, sales, and interactive responses to market dynamics. He has extensive experience with data tools for managing change. He has worked with private enterprises and government to drive quality innovation in healthcare services and information.
Derek Newell, Former President, Castlight Health
Derek Newell is the Former CEO at Jiff, Inc. (11/2011 - 4/2017). He confirms that he can speak to his experience with internet pharmacy, walk-in clinics, mobile health/mHealth, and healthcare navigators. He explains, “I have worked in the digital health industry for 20 years and was the CEO of one of the largest digital health platforms that aggregated solutions for consumers and employers to use in corporate benefit programs. At Jiff, which I was the co-founder and CEO of, we contracted with over 60 point solutions that integrated into our platform, including all of the categories above.” He also confirms that has experience being involved in the design of patient-driven health insurance plans, noting “We worked closely with self-insured employers to design benefits plans where the behavior and choices of the patient directly impacted the coverage.”
George Tierney, Co-Founder, COO and EVP of Branding, SnapMD
George Tierney brings over 20 years’ experience to SnapMD across multiple skill sets that include product and systems development, organizational design, branding and communications, and enterprise operations. A veteran entrepreneur, George has launched multiple product and services operations and is recognized for his deep understanding of what makes great companies tick. A veteran of the digital agency industry, Mr. Tierney rose through the ranks to multiple prestigious positions including executive creative director and ultimately the founding of his own firm. Hanging his shingle at large agencies such as USWeb/CKS and XOR, George’s teams built large-scale and complex web-based applications, and lead digital media and branding initiatives for national and global brands such as The Coca-Cola Company, Sunbeam and Blue Cross Blue Shield. He is known for his expert knowledge and skill in digital media development, branding, and consumer marketing, as well as launching products to the consumer market. George was also a co-founder of marketing and communications firm QuantumMethod, which served brands in the life science industry and has a significant book of work in cause marketing with notable non-profits such as the American Red Cross.
Moderator: Jerry Nickelsburg, Director and Senior Economist, UCLA Anderson Forecast
Jerry Nickelsburg joined the UCLA’s Anderson School of Management and The Anderson Forecast in 2006. Since 2017 he has been the Director of The Anderson Forecast. He teaches economics in the MBA program with a focus on Asian economies. As the Director of The Anderson Forecast he plays a key role in the economic modeling and forecasting of the National, and California economies. He has conducted research in the areas of labor economics, industrial organization, statistics, and international monetary economics, focusing on the development of new data and the application of economic theory and statistical methods to policy issues. His current academic research is on specific skills, structural unemployment, and on energy efficiency in transportation. He is a regular presenter at Economic Conferences and is cited in the national media including the Financial Times, Wall Street Journal, New York Times, Los Angeles Times, and Reuters. He received his Ph.D. in economics from the University of Minnesota in 1980 specializing in monetary economics and econometrics. He was formerly a professor of Economics at the University of Southern California and has held executive positions with McDonnell Douglas, FlightSafety International, and FlightSafety Boeing during a fifteen-year span in the aviation business. He also held a position with the Federal Reserve Board of Governors developing forecasting tools, and has advised banks, investors and financial institutions. From 2000 to 2006, he was the Managing Principal of Deep Blue Economics, a consulting firm he founded. He has been the recipient of the Korda Fellowship, USC Outstanding Teacher, India Chamber of Commerce Jubilee Lecturer, and he is a Fulbright Scholar. He has published over 100 scholarly and popular articles on monetary economics, economic forecasting and analysis, labor economics, and industrial organization and he is the author of two books on monetary economics and exchange rates.
Social Impact in Healthcare (5+Moderator)
Riley Arntz, Founder & CEO, Laso Concepts
Riley launched Laso Concepts in 2016 in response to his own personal journey with chronic substance abuse that led him to seek addiction treatment multiple times in early adulthood. Through his experience and subsequent research, he found that treatment providers are mostly well intentioned, but ill equipped to provide an actionable long-term solution. Utilizing his background in technology, he developed a platform (Laso) that leverages AI to automate patient compliance and serve insights to team members proactively.
Riley has secured a strategic partnership with the #1 EMR (electronic medical records) company in the US, KIPU Systems, to ensure seamless integration with users and to access their network of over 1,100 treatment providers. Peter Walstrom (EVP, Business Development) says: “Laso is addressing the right problem at the right time, industry wide patient compliance is the puzzle that needs to be solved.”
Edmond Banayan (B.A. '94), Chair of Los Angeles Venture Association (LAVA) Healthcare & CEO of Chronaly Inc.
Mr. Banayan is the Chairman of Los Angeles Venture Association (LAVA) Healthcare. He has founded and led business ventures in healthcare, technology, and services. As Co-Founder and CEO of Chronaly Inc. (Chronaly), Mr. Banayan leads a multi-disciplinary team in their mission to develop and commercialize digital health applications for developmental disabilities such as Autism Spectrum Disorder, Bipolar Disorder, and Attention Deficit Hyperactivity Disorder. Chronaly’s dedicated team is pushing the frontier of digital health and patient care by applying advancements such as big data and machine learning to improve care coordination, treatments, and health outcomes for the millions of children and adults across the world with developmental disabilities. Mr. Banayan attended UCLA for his undergraduate degree and graduated with honorable mentions. Subsequent to UCLA, he received his Master of Business Administration from University of Illinois and his Master of Science in Marketing from Northwestern University.
Chris Esguerra, MD, MBA, Senior Medical Director, Blue Shield of California Promise Health Plan
An experienced health care leader, Chris Esguerra, MD, MBA, CHCQM has worked in health care provider and systems leadership, managed care, case management, utilization management, quality, and pharmacy. His work also addressed health care and health plan operations alongside compliance with Medicare, Medi-Cal, and Knox Keene lines of business. He has led significant efforts around integration of care, addressing social determinants of health, and helping people remain and age in the community with appropriate long terms services and supports. He led the primary and behavioral health care integration work at San Mateo County Behavioral Health and Recovery Services called Total Wellness, addressing not only primary and behavioral health care for those with serious mental illness, but also establishing peer supports, addressing nutrition, enhancing social connectedness, and improving physical activity in this cohort. At Health Plan of San Mateo, he facilitated the effort to transition institutionalized members into the community with a combination of intensive case management, housing services and support, government services support, and community based services. This effort included addressing nutrition, housing, social connectedness, independent living skills support, in home support services needs, and promoting self management in addition to strong primary care supported by strong care coordination. He has helped provider organizations enhance their care delivery strategy and shaped strategic growth. He has also helped other organizations evolve their capabilities in identifying social determinants of health as they interact with physical and behavioral health conditions to better target and improve services and interventions.
Dr. Esguerra is board certified in both Psychiatry and Health Care and Quality Management and is a Fellow of the American Psychiatric Association. He attended the University of Southern California as both an undergraduate (B.S. Chemistry) and for medical school. He completed his residency training in Psychiatry at San Mateo County Behavioral Health and Recovery Services Psychiatry Residency Training Program. He also received his MBA in business management from the Isenberg School of Management at the University of Massachusetts at Amherst.
Andrew Kin, Vice President, Clinical Enterprise, DaVita
Andrew Kin currently leads DaVita’s Clinical Enterprise, a team dedicated to improving clinical outcomes and driving patient-centered care for DaVita Kidney Care, in partnership with the CMO. Previously, Andrew led national ESRD operations for DaVita’s integrated care business VillageHealth.
He was a past principal at Bain & Company, where he spent 10 years driving growth and operations excellence at Fortune 500 and mid-market firms.
Andrew also serves as board chair for Gabriella Charter Schools, a dance-themed charter school organization serving underprivileged children. Andrew received his MBA from Stanford and earned an AB in applied mathematics and computer science from Harvard. He currently lives in Los Angeles with his wife, Heather, and children, Nathan and Ella.
Jeannette Tsuei (B.A. '03), Director of Strategy, AppliedVR
Jeannette has over 10 years of experience both in and outside of healthcare. At applied VR, she negotiates, plans and executes alliances and collaborative business relationships with healthcare institutions, pharma, and medical device companies. Jeannette has worked both in and out of health care. Prior to her current role, she helped improve patient experience and backend operations at Cedars-Sinai and informed brand and design strategy for B2B and B2C companies across several industries.
Moderator: Leah Maddock Loh (EMBA '19), MPH, Product Manager, Kaiser Permanente
Leah Maddock Loh, MPH, is a Project Manager with Kaiser Permanente working to decrease health disparities through equitable and patient-centered care. She earned her BA in Cultural Anthropology at UC Berkeley and her Master of Public Health at UCLA Fielding. She has 15 years’ experience as a researcher, 10 in reproductive health and health policy research. She has dedicated her career to improving the health and well-being of others and improving the community around her. Outside of work you’ll find Leah enjoying time with her husband and son, hiking, earning her MBA, and working to launch her startup, Bump to Bundle.
Emerging Applications for Big Data & AI in Health IT (4+Moderator)
Alvin Tam, Chief of Staff, Deep 6 AI
Alvin has 10+ years of healthcare strategy and operations experience where he’s helped leading pharmaceutical and medical device manufacturers with their corporate and commercial strategy. As Chief of Staff at Deep 6 AI, Alvin is very much involved with all business aspects, specifically heading business operations, customer success, and strategic partnerships. Prior to Deep 6 AI, he was an Engagement Manager at PwC / Strategy& where he consulted and advised healthcare leaders on their core business issues. He specialized in market entry, commercialization, and market access. Alvin received his MBA from the UCLA Anderson School of Management and a BA also from UCLA.
Kevin Baldwin, Informatics Portfolio Manager, UCLA Health Sciences
Kevin Baldwin is currently the UCLA Health Sciences Informatics Portfolio Manager, the President of UCLA Staff Assembly, and an Adjunct Professor of Healthcare Systems Engineering at Loyola Marymount University. He is engaged in all aspects of understanding and promoting effective organization, analysis, management, and use of clinical information in electronic health records (EHRs). His previous roles include experience in clinical research and ambulatory administration.
Kerry Weinberg, Sr. Data Scientist, Head of Data Science for Digital Health & Innovation, Amgen
Kerry Weinberg leads Data Science for Digital Health & Innovation at Amgen. Her team focuses on applying emerging data analytic techniques like machine learning and artificial intelligence to improve Amgen’s agility, better reach patients, and improve digital health by better identifying patients, treating them, and enabling their adherence. Prior to this role, Kerry led AI strategy for Process Development at Amgen. Before joining Amgen, Kerry received her MBA and M.S. Biological Engineering from MIT as part of the Leaders for Global Operations Program. She previously led systems engineering efforts for high-speed cell sorters at Beckman Coulter. Kerry holds a B.S. Biological Engineering also from MIT.
Vamsi Chandra, Co-Founder and CEO, Enlightiks
Vamsi is a serial entrepreneur with 3 successful exits and 8 M&A transactions during his 20 years entrepreneurial journey. He has built 16 products, over 60 millions of lines of code and implemented them at thousands of customers across 38 countries in 4 continents. Vamsi has been a Healthcare advisor to various Governments in Asia and is a board member of the prestigious HIMSS (APAC India Chapter). Vamsi built India's first telemedicine network and built one of the largest cluster computers (was called as India's first private super computer) in 1999-2000. His last company Enlightiks was an advanced Analytics and AI company and its platform Querent is the 8th largest Provider analytics platform globally with 31 million patients on the platform. Vamsi has published 8 papers in AI and Microsoft CEO Satya Nadella wrote about Enlightiks and Vamsi in his book 'Hit Refresh'. Vamsi sold Enlightiks to Practo in 2016 and till January 2019 was its Senior Vice President of AI & Analytics.
Moderator: Jennifer McCaney, Professor, UCLA
Jennifer McCaney, PhD, is the Executive Director of UCLA Biodesign, an early-stage innovation program for healthcare technology and Associate Director of the UCLA California Translational Science Institute. Jennifer is an Assistant Professor in the Department of Medicine at the UCLA David Geffen School of Medicine and a Lecturer at the Anderson School of Management where she leads courses on disruptive technology and entrepreneurship in healthcare. A co-founder of Hourglass Technologies, a Stanford Biodesign company, Jennifer led early product development and also launched the MedTech Innovator Accelerator, which grew from an initial cohort of 20 companies to over 150 alumni with a combined $700M in funding. Jennifer has worked extensively with start-up companies in medtech, digital health and diagnostics, as well as business development executives from leading manufacturers, including J&J, Amgen, Baxter, BD, Olympus, and others in her role as the Director of MedTech Innovator. A Fulbright Scholar, Jennifer completed her PhD in mechanical engineering at Stanford and MS in biomedical engineering from the University of New South Wales. Jennifer holds an MS and BS in mechanical engineering from MIT where she was a Draper Fellow and a BS from the MIT Sloan School of Management.
David Geller, Co-Founder and CEO, Logical Medical SolutionsDavid is the Co-founder and Chief Executive Officer of Logical Medical Systems, Inc. Logical Medical Systems develops logistics platforms and innovative cross-platform mobile applications that improve workflow efficiency and increase employee satisfaction in hospitals and private medical practices. Prior to co-founding Logical Medical Systems, David founded and served as the CEO of TopLine Game Labs. Before that, David was the President & COO of Dreamworks Animation Mobile Products Incubator and a Product Executive at Yahoo! David received his BA from the University of Michigan and his MBA from UCLA Anderson.
Kathryn Zavala, VP, Operations and Business Development, MedTech Innovator
Kathryn is the VP, Operations & Business Development at MedTech Innovator, a nonprofit global competition and accelerator for medical device, digital health, and diagnostic companies. Kathryn previously held a position as Senior Technology Fellow at the UCLA Technology Development Group, where she assisted with the commercialization of university technologies. At Campbell Alliance, Kathryn developed launch strategies for biopharma clients. She received her BS from UC Berkeley, where she majored in Molecular and Cell Biology and Rhetoric. Kathryn earned her PhD in Molecular, Cell, and Developmental Biology from UCLA.
Rick Sanghera, Co-founder & CEO, AtaCor Medical, Inc.
Rick has spent over 20 years within the Cardiac Rhythm Management industry, with various roles at Guidant, Cameron Health and Boston Scientific, including 10 years dedicated to the development of the world's first subcutaneous implantable defibrillator system (S-ICD). He is now Co-Founder and CEO of AtaCor Medical, where they are developing the world’s first fully extracardiac pacemaker system. His experience includes positions within R&D as well as field-based roles, creating a foundation that gives him a keen ability to develop novel products that simplify the user experience and improve outcomes for patients. He believes that too often, engineers design products for engineers, rather than the actual user. His goal is to change that mentality to ensure the needs of patients and the medical community always come first.
Rick has proven leadership in research and engineering, a history of cultivating worldwide physician-industry collaborations and he holds over 50 patents in the Cardiac Rhythm Management field. Rick earned a BSc degree in Electrical Engineering from the University of Washington and an MBA from Oxford. He enjoys traveling with his wife, sailing, and golf…and his self described “mediocre” guitar and piano skills won’t threaten his dedication to AtaCor anytime soon.
Robbins Schrader, Co-founder and CEO, SafeRide Health
SafeRide began in 2014 when Robbins, Whit (brother), and Ben (co-founder) began exploring a solution to DUI (Robbins and Whit lost a close friend). Over three years the team built and tested solutions for child mobility, elder mobility and finally non-emergency medical transport. In 2016, Robbins left his role as a Project Leader with BCG to launch and scale SafeRide Health.
Robbins is a commissioned Naval Officer (aviation) and following service worked with GE asset management and Skanska AB where he focused on privatized infrastructure assets. While at Wharton, Robbins was a summer associate at Goldman Sachs then joining Alvarez & Marsal as a senior associate in their Private Equity Performance Group. Robbins holds a BA in History from Cornell University and an MBA from the Wharton School at the University of Pennsylvania. In his free time he enjoys spending time with Newman (his 80lb rescue dog) sailing, surfing and skiing.
Moderator: Vivek Rao, Vivek Rao, Co-founder & CEO, Foundation AI
Vivek is co-founder and CEO of Foundation AI, an artificial intelligence and machine learning development studio that helps companies define their data strategies, build Ai-native products and processes, and supplement their teams with skilled data science talent. Prior to co-founding Foundation AI, Vivek served as head of business and legal affairs for Enlightiks, a healthcare analytics company, until its acquisition in 2016, and as an advisor to several other technology companies. Vivek earned his BS from USC, his JD from UCLA School of Law, and his MBA from UCLA Anderson.
Private Capital: (5+Moderator)
Brad Hively, Principal/Operating Partner, Riordan, Lewis, & Haden Equity Partners
Brad Hively is a Principal at Riordan, Lewis & Haden Equity Partners (RLH Equity), where he focuses on Healthcare Services investments. Prior to joining RLH, Brad was President of Health Essentials Physician Network, the largest post-acute physician group in California. He also served in a variety of leadership roles at Heritage Provider Network, an at-risk medical group and IPA that manages care for over 1 million patients. Earlier in his career Brad was a healthcare-focused investor at TA Associates and General Atlantic. Currently, Brad is also an adjunct lecturer at the USC Price School of Public Policy. Brad holds a BA from UCLA and an MBA from Stanford.
Eric Marton, Venture Partner, Wavemaker Three-Sixty Health
Eric N. Marton has more than 25 years of experience in starting, growing, leading and advising organizations in healthcare and beyond. Eric is a Managing Director at Three-Sixty Advisory Group and a Venture Partner at its sister company, Wavemaker 360 Health – a venture capital firm focused on innovations that drive value-base care. Prior to joining Three-Sixty, Eric was Chief strategy officer at Verity Health, a $1.5 billion health system with six hospital campuses and more than 2000 affiliated physicians, and concurrently served as CEO of the Verity Medical Foundation. He has also served in leadership roles for Cedars-Sinai Health System, Catalyst Venture Group, and UCLA Health, and has been a member of numerous Boards of Directors. In his free time, he is a frequent guest lecturer for schools of business, medicine and public policy at UCLA and USC. Eric holds a BA from UCLA (’93).
Jonathan Bluth, Director, Co-Head of Healthcare, Intrepid Investment Bankers
During a career spanning more than 19 years of healthcare finance experience, Jonathan has assisted clients in mandates, including buy-side and sell-side M&A, capital raising and management consulting. His transactional experience includes key execution roles in the healthcare investment banking group at Deloitte Corporate Finance and the healthcare M&A group at Cowen and Company. Jonathan brings a unique perspective to M&A advisory services, leveraging his prior roles as Management Consultant and Vice President of Finance for a publicly traded healthcare services organization. His operating and consulting roles give him unique insight on revenue cycle management, IT vendor selection, and various cost reduction strategies, as well as divisional budgeting, financial reporting, and buy-side M&A implementation. Over the course of his career, he has advised companies in nearly every healthcare sector, including: behavioral health, dental services, devices, home health, hospice, hospitals, IT, pharmacy, pharmaceuticals, physician groups and revenue cycle management. In his spare time, Jonathan is an active board member for the non-profit Cancer Support Community, which provides supportive care services to oncology patients across the greater Los Angeles area. Jonathan has an MBA from UCLA Anderson (’06) and a BA in History and Sociology of Science, Healthcare Systems from University of Pennsylvania.
Sharon Stevenson, DVM, Ph.D., Co-Founder and Managing Director, Okapi Venture Capital
Sharon is a Managing Director of Okapi Venture Capital, which she co-founded in 2005, and is responsible for the firm's life sciences investments. She led Okapi’s investments in Helixis, Obalon Therapeutics, Orthalign, Wisercare, BioTrace Medical, Focal Therapeutics, Chromacode and WellTok. Prior to founding Okapi, Sharon was Senior Vice President of Technology and Planning for SkinMedica, an early stage pharma company acquired by Allergan. Earlier, she was a Principal with Domain Associates, serving at the same time as President and CFO of Volcano Therapeutics. Sharon's past board affiliations on behalf of Domain include MicroVention, Neuropace, NuVasive, Santarus, SkinMedica, and GenVault. Prior to Domain Associates, she was Executive Director of the Advanced Tissue Sciences/ Smith+Nephew NeoCyte joint venture. Prior to moving to the private sector, Sharon was a tenured Associate Professor in the Department of Orthopedics at the Case Western Reserve University School of Medicine. She is the author of more than 130 publications, including two guest editorships, and has made more than 50 presentations at scientific meetings. Her clinical training was in veterinary surgery and she is a Diplomate of the American College of Veterinary Surgeons (ACVS). She has served on the governing boards of the ACVS and the Orthopedic Research Society and is a member of the Board of Governors of the Pardee RAND Graduate School of Public Policy. Sharon received an MBA from the UCLA Anderson (’00), a PhD in Comparative Pathology from UC Davis, and a Master of Science in Veterinary Pathology and Doctor of Veterinary Medicine from The Ohio State University.
Stuart Collinson, Investor, Partner, Forward Ventures:
Stuart is a partner at Forward Ventures and director or advisor for several biopharmaceutical companies. Dr. Collinson served as the chairman and director of companies including Affinium Pharmaceuticals (acquired by Debiopharm), NovaCardia (acquired by Merck & Co.), Conforma Therapeutics (acquired by Biogen), GeneOhm Sciences (acquired by Becton Dickinson), Cabrellis Pharmaceuticals (acquired by Pharmion, now part of Celgene), Essentialis (acquired by Capnia) and Proprius Pharmaceuticals (acquired by Cypress Biosciences). Previously he was Chairman and CEO of Aurora Biosciences (acquired by Vertex Pharmaceuticals). Aurora’s expertise in ion channel research led to the discovery of breakthrough medicines for cystic fibrosis; Vertex (the combined company) is now valued at ~$50 billion. Stuart held management positions at GlaxoWellcome (now GlaxsoSmithKline) and Baxter International, and was a consultant with The Boston Consulting Group. Dr. Collinson received an MBA from Harvard Business School and a PhD in Physical Chemistry from the University of Oxford.
Moderator: Jennifer Walske, Assistant Professor, UCLA Anderson
Dr. Jennifer Walske is an assistant professor (adjunct) at UCLA Anderson, and serves as the interim faculty director of Impact@Anderson. She is also a Social Impact Fellow at Berkeley-Haas. As a writer, researcher and investor, Dr. Walske sits on numerous for profit and non-profit boards. Her research centers on the funding and scaling of startups, with an emphasis on social startups and social venture capital firms. Dr. Walske has received numerous research and teaching awards including the “best paper” award from NYU Stern’s Social Entrepreneurship Conference and the Cheit Award for Teaching Excellence at Berkeley-Haas. Prior to her academic career, Dr. Walske was an institutional All American ranked investment banking securities analyst and a regular commentator on both CNN and CNBC. Prior to investment banking Dr. Walske served in product marketing roles at Synopsys and Intergraph. She holds a doctorate in strategy and entrepreneurship from Boston University, an MBA from Santa Clara University and a BA in Communication Studies from UC Santa Barbara.